Fujian Genohope Biotech

China peptide API manufacturer in Putian, Fujian. Founded 2019 as a JV of New Hope Group (Fortune 500) and Genovior. GMP facilities for FDA, EMA, PMDA, NMPA compliant production. FDA-inspected, 8 USDMFs, semaglutide line EU GMP certified. US DMFs: Semaglutide 040957, Tirzepatide 040503; Retatrutide and Orforglipron DMFs filed 2025. FDA Green List (September 2025, confirmed May 2026); EU GMP certificate for semaglutide injection line (June 2026); passed second FDA on-site inspection 2026.

Directory assessment: Fujian Genohope Biotech is listed as a CDMO in the peptide supply chain, serving Asia markets from China (Fujian). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.